r.rotation.to⌕ Search stocks, people, sectors
Following this device: dark.
Request a free account

Follow the people · Insider

OD

Oliver Dolan

Insider · Senior Vice President, Finance · KRRO

Oliver Dolan files insider transactions with the SEC as a senior vice president, finance of Korro Bio. We hold 3 disclosed purchases and sales filed since 1 April 2025, 3 of them in the last 90 days.

  • Files forKRRO
  • Disclosed buys and sells3 in all, 3 in the last 90 days
  • Last disclosure10 September 2026

Positions held

1 post we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 1 April 2025 — 9 September 2026Senior Vice President, Finance · Korro Bio 8 Form 4 lines · source: SEC Form 4

Every transaction

8 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing
8 of 8 shown
9 Sep 202610 Sep 2026SEC Form 41 dsold on the open marketKorro Bio6 sharesup +6.8%up +5.7%
8 Sep 202610 Sep 2026SEC Form 42 dsold on the open marketKorro Bio7,347 sharesup +2.2%up +5.7%
15 Jul 202617 Jul 2026SEC Form 42 dwas grantednot a tradeKorro Bio5,500 sharesup +6.0%up +12.7%
16 Jun 202617 Jun 2026SEC Form 41 dsold on the open marketKorro Bio3,383 sharesup +29.5%up +25.0%
2 Feb 20263 Feb 2026SEC Form 41 dwas grantednot a tradeKorro Bioderivative15,000 sharesup +5.8%up +8.7%
2 Feb 20263 Feb 2026SEC Form 41 dwas grantednot a tradeKorro Bioderivative15,000 sharesup +5.8%up +8.7%
15 Dec 202516 Dec 2025SEC Form 41 dwas grantednot a tradeKorro Bio21,482 sharesup +73.5%up +68.0%
1 Apr 20251 Apr 2025SEC Form 40 dwas grantednot a tradeKorro Bioderivative20,000 sharesdown −13.4%down −13.4%

Both percentages are the stock’s move, not Oliver Dolan’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 11 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 8 of the 8 rows shown carry a percentage; the rest are dashes with the reason on the row.

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.

Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.